ArticlePharmacoEconomics - open2019

The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q.

Dawn Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.